Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genentech
5
×
life sciences
national blog main
national top stories
san francisco top stories
5
×
boston blog main
boston top stories
clinical trials
eli lilly
fda
san francisco blog main
indiana blog main
indiana top stories
national
new york top stories
novartis
roche
abbvie
astrazeneca
avapritinib
avexis
biogen
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
celgene
deals
detroit blog main
detroit top stories
europe top stories
gene therapy
investing
johnson & johnson
medullary thyroid cancer
microbiome
new york blog main
What
fda
5
×
drug
approval
approved
bio
blueprint
cancer
medicines
news
regulatory
ret
roche
roundup
therapy
address
approves
atrophy
august
biotech
busy
candidate
carries
certain
companies
currently
daily
days
decisions
designed
devices
digital
disease
drugs
epidemic
evrysdi
fatty
frenzied
friday
genetic
green
Language
unset
Current search:
genentech
×
fda
×
" san francisco top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More